News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

LAXAI Completes Asset Purchase of a Clinical Research Services Company and Files Its Annual Report for 2009


4/19/2010 9:20:06 AM

NEW YORK, April 19, 2010 (GLOBE NEWSWIRE) -- Laxai Pharma Ltd. (OTCBB:LAXAF) (f/k/a NexGen Biofuels, Ltd.), a contract research organization ("CRO"), recently completed an asset purchase of OSR Solutions, Inc. as a platform acquisition to enter into the CRO industry that provides fully integrated services across the drug development spectrum for pharmaceutical customers and simultaneously cease its biofuel operations.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES